Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

osoth inter laboratories co. - iron (iii)-hydroxide polymaltose complex - syrup - 10mg/ml

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

medical horizon ltd - sulfamethoxazole, trimethoprim - suspension oral - 200mg/5ml+40mg/5ml

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

submarino pty ltd - imazapyr - water dispersible granule - imazapyr imidazolinone active 750.0 g /kg - herbicide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

submarino pty ltd - imazapic - water dispersible granule - imazapic imidazolinone active 700.0 g /kg - herbicide

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

eurodrug laboratories (m) sdn. bhd. - iron(iii) hydroxide polymaltose complex -

Canada - English - Health Canada

cheplapharm arzneimittel gmbh - hydroxyurea - capsule - 500mg - hydroxyurea 500mg - antineoplastic agents

Canada - English - Health Canada

mylan pharmaceuticals ulc - hydroxyurea - capsule - 500mg - hydroxyurea 500mg - antineoplastic agents

Canada - English - Health Canada

apotex inc - hydroxyurea - capsule - 500mg - hydroxyurea 500mg - antineoplastic agents

Canada - English - Health Canada

sanis health inc - hydroxyurea - capsule - 500mg - hydroxyurea 500mg - antineoplastic agents

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - hydroxyurea (unii: x6q56qn5qc) (hydroxyurea - unii:x6q56qn5qc) - hydroxyurea 500 mg - significant tumor response to hydroxyurea capsules usp has been demonstrated in melanoma, resistant chronic myelocytic leukemia, and recurrent, metastatic, or inoperable carcinoma of the ovary. hydroxyurea, usp used concomitantly with irradiation therapy is intended for use in the local control of primary squamous cell (epidermoid) carcinomas of the head and neck, excluding the lip. hydroxyurea is contraindicated in patients with marked bone marrow depression, i.e., leukopenia (< 2500 wbc) or thrombocytopenia (< 100,000), or severe anemia. hydroxyurea capsules are contraindicated in patients who have demonstrated a previous hypersensitivity to hydroxyurea or any other component of its formulation.